Your browser doesn't support javascript.
High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease.
Li, Yan; Zhang, Jinyong; Duan, Zilei; Wang, Ning; Sun, Xiangcheng; Zhang, Yanjing; Fu, Li; Liu, Kaiyun; Yang, Yongjun; Pan, Shulei; Shi, Yun; Zeng, Hao; Guo, Gang; Lai, Ren; Zou, Quanming.
  • Li Y; West China Biopharm Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Zhang J; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, 400038, China.
  • Duan Z; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China.
  • Wang N; Kunming National High-Level Biosafety Research Center for Non-Human Primates, Kunming Institute of Zoology, Chinese Academic of Sciences, Kunming, Yunnan, 650107, China.
  • Sun X; West China Biopharm Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Zhang Y; West China Biopharm Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Fu L; The Research Core Facility, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Liu K; The Research Core Facility, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Yang Y; West China Biopharm Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Pan S; Medical Research Center, Southwest Hospital, Army Medical University, Chongqing, 400038, China.
  • Shi Y; West China Biopharm Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Zeng H; West China Biopharm Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Guo G; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, 400038, China.
  • Lai R; West China Biopharm Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. guogang7001@163.com.
  • Zou Q; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, 650223, China. rlai@mail.kiz.ac.cn.
Signal Transduct Target Ther ; 6(1): 356, 2021 09 29.
Article in English | MEDLINE | ID: covidwho-1442756
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pharmaceutical Preparations / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-021-00763-5

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pharmaceutical Preparations / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-021-00763-5